Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1994-3-18
pubmed:abstractText
Patients with unstable angina despite intensive medical therapy, ie, refractory angina, are at high risk for developing thrombotic complications: myocardial infarction or coronary occlusion during percutaneous transluminal coronary angioplasty (PTCA). Chimeric 7E3 (c7E3) Fab is an antibody fragment that blocks the platelet glycoprotein (GP) IIb/IIIa receptor and potently inhibits platelet aggregation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0009-7322
pubmed:author
pubmed:issnType
Print
pubmed:volume
89
pubmed:owner
NLM
pubmed:authorsComplete
N
pubmed:pagination
596-603
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:7508826-Adult, pubmed-meshheading:7508826-Aged, pubmed-meshheading:7508826-Angina, Unstable, pubmed-meshheading:7508826-Angioplasty, Balloon, Coronary, pubmed-meshheading:7508826-Antibodies, Monoclonal, pubmed-meshheading:7508826-Bleeding Time, pubmed-meshheading:7508826-Coronary Angiography, pubmed-meshheading:7508826-Female, pubmed-meshheading:7508826-Humans, pubmed-meshheading:7508826-Immunoglobulin Fab Fragments, pubmed-meshheading:7508826-Integrins, pubmed-meshheading:7508826-Male, pubmed-meshheading:7508826-Middle Aged, pubmed-meshheading:7508826-Myocardial Ischemia, pubmed-meshheading:7508826-Platelet Function Tests, pubmed-meshheading:7508826-Platelet Glycoprotein GPIIb-IIIa Complex, pubmed-meshheading:7508826-Postoperative Complications, pubmed-meshheading:7508826-Treatment Outcome
pubmed:year
1994
pubmed:articleTitle
Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina. European Cooperative Study Group.
pubmed:affiliation
Thoraxcenter, Rotterdam, The Netherlands.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't